Skip to content

Insperity

US · NSP #2868 by market cap Listed 1970
48.23 +1.81 +3.90%
Live - 5344 symbols - heartbeat 478s ago · 2026-10-07 19:54
After-hours 48.23 0.00%
Market cap
1.84B
P/E (TTM)
-109.61
P/B
30.20
EPS
-0.19
Reader sentiment Are you bullish or bearish on NSP?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Ownership Signal how this is computed

Mixed / stable
  • The number of reporting institutions increased by 1 in the most recent period (2026/Q3).
  • Total institutional ownership (as a % of shares) was little changed.

Institutional ownership

Held by institutions
113.16% -0.08pp
Institutions
324 +1
As of
2026/Q3 vs. prior period

Ownership vs. money flow

Aligned

Institutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Holder types

Mutual Fund92.17%
Hedge Fund10.45%
Public Company7.77%
Individual/Insider6.22%
Government Pension Fund1.10%
Private Company0.52%
Insurance Company0.51%
VC/PE Fund0.43%
Family Office/Trust0.15%

Top holders as of 2026-06-30

BlackRock 14.53% · 5.55M sh
Reinhart Partners, LLC 8.65% · 3.30M sh
EARNEST Partners, LLC 8.12% · 3.10M sh
Vanguard Portfolio Management, LLC 5.81% · 2.22M sh
Managed Account Advisors LLC 5.72% · 2.19M sh
SEI Investments Company 4.92% · 1.88M sh
Vanguard Capital Management, LLC 4.77% · 1.82M sh
Paul Sarvadi 4.47% · 1.71M sh
Charles Schwab Investment Management 4.27% · 1.63M sh
State Street Global Advisors 3.80% · 1.45M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 40 buys · 10 sells

NameRoleStake
Paul Sarvadi Chairperson & CEO 4.47%
Richard Rawson Director 0.61%
Arthur A. Arizpe President 0.45%
James Allison Executive VP of Comprehensive Benefits Solutions & Chief Profitability Officer 0.17%
Carol Kaufman Independent Director 0.12%
Randall Mehl Independent Director 0.07%
Timothy Clifford Lead Independent Director 0.06%
Ellen Masterson Independent Director 0.05%
John Lumelleau Independent Director 0.05%
Latha Ramchand Independent Director 0.04%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-09-10 Paul Sarvadi Chairperson & CEO Other Disposition -7,500 --
2026-08-16 Paul Sarvadi Chairperson & CEO Other Disposition -30,000 --
2026-06-02 Paul Sarvadi Chairperson & CEO Open Market Acquisition +233,000 $34.05
2026-05-17 W. Wilmington Independent Director Other Acquisition +6,201 --
2026-05-17 Richard Rawson Director Other Acquisition +6,201 --
2026-05-17 Carol Kaufman Independent Director Other Acquisition +6,201 --
2026-05-17 John Morphy Independent Director Other Acquisition +6,201 --
2026-05-17 Timothy Clifford Lead Independent Director Other Acquisition +6,201 --
2026-05-17 John Lumelleau Independent Director Other Acquisition +6,201 --
2026-05-17 Eli Jones Independent Director Other Acquisition +6,201 --
2026-05-17 Randall Mehl Independent Director Other Acquisition +6,201 --
2026-05-17 Ellen Masterson Independent Director Other Acquisition +6,201 --
2026-05-17 Latha Ramchand Independent Director Other Acquisition +6,201 --
2026-05-04 Paul Sarvadi Chairperson & CEO Open Market Acquisition +100,000 $28.20–30.00
2026-03-18 Paul Sarvadi Chairperson & CEO Open Market Acquisition +201,987 $22.53–23.93
2026-03-10 Christian Callens Senior VP of Legal, General Counsel & Secretary Open Market Acquisition +1,250 $19.28
2026-03-10 Ellen Masterson Independent Director Open Market Acquisition +1,200 $19.90
2026-03-09 James Allison Executive VP of Comprehensive Benefits Solutions & Chief Profitability Officer Open Market Acquisition +10,000 $20.45
2026-03-02 Paul Sarvadi Chairperson & CEO Sale to Issuer -11,272 $21.13–22.21
2026-03-02 Paul Sarvadi Chairperson & CEO Other Acquisition +2,944 --

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.